Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
- DOI
- 10.1182/bloodadvances.2023010362
- Published
- 2024 Feb 13
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2023010362,
title = {Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.},
author = {Bracken SJ and Suthers AN and DiCioccio RA and Su H and Anand S and Poe JC and Jia W and Visentin J and Basher F and Jordan CZ and McManigle WC and Li Z and Hakim FT and Pavletic SZ and Bhuiya NS and Ho VT and Horwitz ME and Chao NJ and Sarantopoulos S},
year = {2024},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2023010362},
url = {https://doi.org/10.1182/bloodadvances.2023010362}
}RIS
TY - JOUR TI - Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions. AU - Bracken SJ AU - Suthers AN AU - DiCioccio RA AU - Su H AU - Anand S AU - Poe JC AU - Jia W AU - Visentin J AU - Basher F AU - Jordan CZ AU - McManigle WC AU - Li Z AU - Hakim FT AU - Pavletic SZ AU - Bhuiya NS AU - Ho VT AU - Horwitz ME AU - Chao NJ AU - Sarantopoulos S PY - 2024 JO - Blood advances DO - 10.1182/bloodadvances.2023010362 UR - https://doi.org/10.1182/bloodadvances.2023010362 ER -
APA
SJ, B., AN, S., RA, D., H, S., S, A., JC, P., W, J., J, V., F, B., CZ, J., WC, M., Z, L., FT, H., SZ, P., NS, B., VT, H., ME, H., NJ, C., & S, S. (2024). Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.. Blood advances. https://doi.org/10.1182/bloodadvances.2023010362
Source records
- pubmed · retrieved 2026-09-26T13:15:12.803Z